UPL Limited Strong Q3 Results Driven by Volume Growth and Improved Margins

UPL Limited announced strong Q3 and 9M FY26 results, driven by robust volume growth and improved financial discipline. Q3 revenue increased by 12% to ₹12,269 cr, while EBITDA grew by 13%. The company sustained momentum through broad-based EBITDA growth and financial improvements, leading to an improved PBT by 90% and Operational PATMI by 45%. Focus remains on balance sheet strengthening and capital productivity.

Key Financial Highlights

UPL Limited reported a strong performance for Q3 and 9M FY26, marked by significant improvements in revenue and profitability:

  • Revenue: ₹12,269 cr in Q3 (up 12%) and ₹33,504 cr for 9M (up 8%)
  • Contribution Margin: 42.6% in Q3 and 9M, reflecting improvements of +160 bps and +320 bps, respectively.
  • EBITDA: ₹2,434 cr in Q3 (up 13%) and ₹5,941 cr for 9M (up 22%).
  • PBT: ₹671 cr in Q3 and ₹1,265 cr for 9M.
  • Operational PATMI: ₹452 cr in Q3 and ₹784 cr for 9M.

Balance Sheet Strength

The company demonstrated improved balance sheet management:

  • Net Debt: Reduced to ₹23,317 cr.
  • Net Debt/EBITDA: Improved to 2.5x.
  • Net Debt/Equity: Improved to 0.6x.
  • NWC Days: 116 Days.

Segment Performance

Strong Q3 performance was led by the Crop Protection and Seeds platforms. Robust overall YTD performance across all platforms. Key highlights include:

  • UPL Corp: Led by growth across all key regions.
  • UPL SAS: Volume led growth, supported by lower product returns.
  • Advanta: Higher volumes in field corn, grain sorghum, and canola.
  • SUPERFORM: Agchem reduction offset by contract manufacturing and SSC growth.

Regional Performance

Q3 growth across all regions, led mainly by Latin America, Europe and Rest of World.

  • Latin America: Led by herbicides and field corn.
  • Europe: Led mainly by herbicide volumes and NPP.
  • India: Led by seeds, supported by crop protection.
  • Rest of World: Strong growth led by crop protection (China, Africa).

FY26 Outlook

The company reaffirmed its FY26 guidance, anticipating:

  • Revenue growth of 4-8%.
  • EBITDA growth of 12-16%.

Source: BSE

Previous Article

Ahluwalia Contracts Board Meeting Scheduled to Approve Q3 2026 Results and Amalgamation Scheme

Next Article

Dalmia Bharat Analyst and Investor Meeting Schedule Announced